Analyst Ratings for Mast Therapeutics (mstx)

mstx Rating Summary

mstx Price Target Summary

* Over Last 12-Mos
  |   Expand Research on mstx
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $2.17 (+333.3%) * Over Last 12-Mos
Rating Score: 10 / 10
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
11/17/2014 Canaccord Genuity New Coverage Buy
(N/A)
3.00
(N/A)
0.45 0.50 11.11% Details
8/6/2014 Laidlaw
» Updated 9/8/2014
New Coverage Buy
(N/A)
2.50
(N/A)
0.56 0.50 -10.71% Details
Like MSTX Ratings? Also take a look at MRK

MSTX Ratings News